Filing Details

Accession Number:
0001127602-20-007853
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-26 10:15:49
Reporting Period:
2020-02-24
Accepted Time:
2020-02-26 10:15:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc. CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1141722 C James Foster 251 Ballardvale Street
Wilmington MA 01887
Chairman, President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-24 24,008 $88.05 313,054 No 4 M Direct
Common Stock Acquisiton 2020-02-24 20,295 $109.34 333,349 No 4 M Direct
Common Stock Disposition 2020-02-24 36,702 $166.51 296,647 No 4 S Direct
Common Stock Disposition 2020-02-24 6,156 $167.44 290,491 No 4 S Direct
Common Stock Disposition 2020-02-24 1,445 $168.34 289,046 No 4 S Direct
Common Stock Disposition 2020-02-24 750 $167.83 750 No 4 S Indirect By Trust
Common Stock Disposition 2020-02-24 2,250 $167.83 2,250 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect By Trust
No 4 S Indirect By Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2020-02-24 24,008 $0.00 24,008 $88.05
Common Stock Stock Options (Right to Buy) Disposition 2020-02-24 20,295 $0.00 20,295 $109.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,009 2018-02-24 2022-02-24 No 4 M Direct
40,591 2019-02-23 2023-02-23 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,800 Indirect 2018 GRAT
Common Stock 25,000 Indirect 2019 GRAT
Common Stock 340 Indirect By Trust
Common Stock 10,000 Indirect Held By Spouse
Footnotes
  1. This sale occurred pursuant to a 10b5-1 Trading Plan.
  2. This transaction was executed in multiple trades at prices ranging from $166.035 to $167.025. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $167.05 to $167.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $168.08 to $169.005. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. Held by trust of which the reporting person is trustee. The reporting person disclaims beneficial ownership of these securities.
  6. Held by trust of which the reporting person is trustee. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.